Cancer Research Technology
Log in Register
Menu

Anti-ATG13, Polyclonal [ATG13]

Invented by Dr Sharon Tooze at The Francis Crick Institute

Info

Catalogue Number 151612
Applications WB
Antigen/Gene or Protein Targets ATG13
Reactivity Human
Relevance Autophagy has been implicated in a number of medical contexts, such as cancer, neurodegeneration, and immunity. The serine-threonine protein kinase Atg1 was originally identified as a critical autophagy regulator in yeast. Full kinase activity of Atg1 in yeast requires its binding partners Atg13 and Atg17. Atg13 only binds in the unphosphorylated state, and its dephosphorylation has been shown to be TOR dependent.
Host Rabbit
Immunogen C-terminal synthetic peptide
Notes This antibody is not available for licence, please refer to supplier information to find a source of the antibody.
Research Area Apoptosis and Programmed Cell Death, Cancer, Cell Signaling & Signal Transduction, Metabolism

References: 2 entries

Chan et al. 2009. Mol Cell Biol. 29(1):157-71. PMID: 18936157.

Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism.

Europe PMC ID: 18936157


Add a reference

References: 2 entries

Chan et al. 2009. Mol Cell Biol. 29(1):157-71. PMID: 18936157.

Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism.

Europe PMC ID: 18936157


Add a reference

References: 2 entries

Chan et al. 2009. Mol Cell Biol. 29(1):157-71. PMID: 18936157.

Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism.


Add a reference


This reagent does not have any reviews at the moment.